Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

SXTCSXTC
3 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in China SXT Pharmaceuticals, Inc.

No. Geode Capital Management exited its SXTC (China SXT Pharmaceuticals) position in Q1 2026. Its Q4 2025 13F listed 53,671 shares worth $85,873. Geode Capital Management first reported SXTC in Q3 2025 and held it in 2 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$85,336

Total Shares Change

-53,671

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$13,440.00
0
2025-Q4
Unchanged
53,671
0.0%
$85,8730.0%$1,920,000.00
0
2025-Q3
New
53,671
-
$85,3360.0%$1,884,000.00
33

Other major holders of SXTC: CITADEL ADVISORS LLC, Invesco Ltd., UBS Group AG

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used